Danaher's bid to acquire medical technology company Masimo reviewed in Australia
MLex Summary: Global science and technology company Danaher Corporation’s proposal to acquire 100 percent of the outstanding share capital of Masimo Corporation will face review by Australia’s antitrust watchdog. In a...To view the full article, register now.
Already a subscriber? Click here to view full article